iAtoday
Frédéric Leblanc, Pharmacist and Strategic Leader, Drug Programs, takes part in the Express Scripts Canada 2025 Outcomes Conference.
At the conference, he shares his observations on two key topics: women’s health and the treatment of attention-deficit/hyperactivity disorder (ADHD). The latest trends in cancer treatment and the use of biosimilars are also discussed.
If you would like to know more about these trends and their impact on drug plans, we invite you to view this free conference available on demand. It is also available in French.
In addition, if you would like to learn more about our sustainable healthcare initiatives, including PharmAssist®, our one-stop shop for drug management, contact your iA Financial Group Account Executive.
Organizations wanting to support the total wellbeing of their plan members can rely on our solutions, which not only optimally meet their needs, but also offer a simplified, personal experience.
Also in this issue
- LIMRA Workplace Benefits Conference | We were there
- Appointments | Our group insurance team is growing
- Canada Post | Risk of mail delivery interruption
- Grand défi Pierre Lavoie | On the move to inspire youth
- ATTITUDE portfolios | A brand-new design coming soon
- Federal elections | Insights from our economists
- Quarterly Update | March 31, 2025 edition now available
- Managing obesity in the workplace: a beneficial choice
- Top 10 drugs 2024 | Our experts’ analysis
- Travel assistance | Resources for worry-free travel